Clinical trial
The EASYTRAK EPI Clinical Investigation
NCT00158925 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00158925 |
|---|---|
| Title | The EASYTRAK EPI Clinical Investigation |
| Official title | The EASYTRAK EPI Clinical Investigation |
| Acronym | EASYTRAK EPI |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bradycardia, Congestive Heart Failure |
| Intervention type | Device |
| Interventions | EASYTRAK EPI lead |
| Enrollment | 100 |
| Start date | Sep 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | May 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: